Literature DB >> 8039934

Giardia lamblia infections in adult mice.

L G Byrd1, J T Conrad, T E Nash.   

Abstract

An adult mouse-Giardia lamblia model was developed and used to study host-parasite interactions, including antigenic variation. The H7/1 clone of isolate GS infected mice consistently and produced infections in 14 mouse strains tested. Infection patterns were mouse strain and Giardia isolate dependent. Antigenic variation occurred in immunocompetent mice but not in mice with severe combined immunodeficiency.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8039934      PMCID： PMC302999          DOI： 10.1128/iai.62.8.3583-3585.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  25 in total

1.  Characterization of a Giardia lamblia variant-specific surface protein (VSP) gene from isolate GS/M and estimation of the VSP gene repertoire size.

Authors:  T E Nash; M R Mowatt
Journal:  Mol Biochem Parasitol       Date:  1992-04       Impact factor: 1.759

2.  Cysteine-rich variant surface proteins of Giardia lamblia.

Authors:  A Aggarwal; J W Merritt; T E Nash
Journal:  Mol Biochem Parasitol       Date:  1989-01-01       Impact factor: 1.759

3.  Restriction-endonuclease analysis of DNA from 15 Giardia isolates obtained from humans and animals.

Authors:  T E Nash; T McCutchan; D Keister; J B Dame; J D Conrad; F D Gillin
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

4.  Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile.

Authors:  D B Keister
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

5.  Antigenic variation in Giardia lamblia: cellular and humoral immune response in a mouse model.

Authors:  B Gottstein; G R Harriman; J T Conrad; T E Nash
Journal:  Parasite Immunol       Date:  1990-11       Impact factor: 2.280

6.  Antibody response to Giardia muris trophozoites in mouse intestine.

Authors:  M F Heyworth
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Chronic Giardia muris infection in anti-IgM-treated mice. I. Analysis of immunoglobulin and parasite-specific antibody in normal and immunoglobulin-deficient animals.

Authors:  D P Snider; J Gordon; M R McDermott; B J Underdown
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

8.  Response of Peyer's patch lymphocyte subsets to Giardia muris infection in BALB/c mice. II. B-cell subsets: enteric antigen exposure is associated with immunoglobulin isotype switching by Peyer's patch B cells.

Authors:  J R Carlson; M F Heyworth; R L Owen
Journal:  Cell Immunol       Date:  1986-01       Impact factor: 4.868

9.  Giardiasis in mice: analysis of humoral and cellular immune responses to Giardia muris.

Authors:  R F Anders; I C Roberts-Thomson; G F Mitchell
Journal:  Parasite Immunol       Date:  1982-01       Impact factor: 2.280

10.  Sequential changes of lamina propria immunoglobulin-containing cells in immune intact and immunosuppressed mice infected with Giardia lamblia.

Authors:  V K Vinayak; R Khanna; K Kum
Journal:  Immunol Cell Biol       Date:  1989-06       Impact factor: 5.126
View more
  43 in total

1.  High-throughput Giardia lamblia viability assay using bioluminescent ATP content measurements.

Authors:  Catherine Z Chen; Liudmila Kulakova; Noel Southall; Juan J Marugan; Andrey Galkin; Christopher P Austin; Osnat Herzberg; Wei Zheng
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model.

Authors:  Gabriela Jenikova; Petr Hruz; Mattias K Andersson; Noa Tejman-Yarden; Patricia C D Ferreira; Yolanda S Andersen; Barbara J Davids; Frances D Gillin; Staffan G Svärd; Roy Curtiss; Lars Eckmann
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

3.  Discovery of novel antigiardiasis drug candidates.

Authors:  Liudmila Kulakova; Andrey Galkin; Catherine Z Chen; Noel Southall; Juan J Marugan; Wei Zheng; Osnat Herzberg
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

4.  Tumour necrosis factor alpha contributes to protection against Giardia lamblia infection in mice.

Authors:  P Zhou; E Li; T Shea-Donohue; S M Singer
Journal:  Parasite Immunol       Date:  2007-07       Impact factor: 2.280

5.  Cytokines, Antibodies, and Histopathological Profiles during Giardia Infection and Variant-Specific Surface Protein-Based Vaccination.

Authors:  Marianela C Serradell; Pablo R Gargantini; Alicia Saura; Sergio R Oms; Lucía L Rupil; Luciana Berod; Tim Sparwasser; Hugo D Luján
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

6.  Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram.

Authors:  Andrey Galkin; Liudmila Kulakova; Kap Lim; Catherine Z Chen; Wei Zheng; Illarion V Turko; Osnat Herzberg
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

7.  Resistance to reinfection in mice as a vaccine model for giardiasis.

Authors:  Erqiu Li; Mingqiu Liu; Steven M Singer
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

8.  Efficacies of zinc-finger-active drugs against Giardia lamblia.

Authors:  T Nash; W G Rice
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Phosphoinositide 3-kinase-dependent inhibition of dendritic cell interleukin-12 production by Giardia lamblia.

Authors:  Joel Désiré Kamda; Steven M Singer
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

10.  Draft genome sequencing of giardia intestinalis assemblage B isolate GS: is human giardiasis caused by two different species?

Authors:  Oscar Franzén; Jon Jerlström-Hultqvist; Elsie Castro; Ellen Sherwood; Johan Ankarklev; David S Reiner; Daniel Palm; Jan O Andersson; Björn Andersson; Staffan G Svärd
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.